Skip to main content
Premium Trial:

Request an Annual Quote

Codex DNA: Synthetic SARS-CoV-2 B.1.617

Codex DNA has released a full-length synthetic genome for the SARS-CoV-2 Delta variant (B.1.617), constructed and manufactured using the firm's BioXp 3250 synthetic biology benchtop system. The genome can be used by researchers to develop therapies, vaccines, and diagnostics to slow the spread of the variant. Overall, Codex currently offers 13 different SARS-CoV-2 synthetic genomes.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.